According to MeiraGTx's latest financial reports the company's current revenue (TTM) is $14.01 M. In 2022 the company made a revenue of $15.92 M a decrease over the years 2021 revenue that were of $37.7 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $14.01 M | -11.95% |
2022 | $15.92 M | -57.77% |
2021 | $37.7 M | 142.24% |
2020 | $15.56 M | 17.09% |
2019 | $13.29 M | |
2018 | N/A | |
2017 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Organovo ONVO | $0.24 M | -98.27% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $21.83 M | 55.80% | ๐ฌ๐ง UK |
Novavax NVAX | $0.69 B | 4,847.29% | ๐บ๐ธ USA |
Novocure
NVCR | $0.50 B | 3,533.72% | Jersey |